Ocugen’s vaccine candidate Covaxin met both co-primary endpoints in study
Biopharmaceutical company Ocugen announced its COVID-19 vaccine candidate Covaxin, developed by Bharat Biotech, showed positive results in the U.S. trial. Ocugen, a Biotechnology Innovation […]
Ocugen’s vaccine candidate Covaxin met both co-primary endpoints in study Read More »